From November 11-14, 2024, the highly regarded annual event MEDICA Exhibition was successfully held in Dusseldorf, Germany, and successfully concluded. After extensive preparation over the past months,the Hipro team presented an impressive array of products at Medica,once again showcasing our team's expertise and the exceptional uniqueness of our products.
As everyone knows MEDICA is one of the largest medical B2B trade fairs in the world. In 2024 it gather with over 5,000 exhibitors from 72 countries and 80,000 visitors. It brings together leading medical companies, innovative technologies, and healthcare professionals from around the world. The event features exhibitions, forums, and conferences covering a wide range of topics, including medical devices, diagnostics, digital health, and hospital technologies. Medica serves as a key platform for showcasing advancements, fostering partnerships, and driving innovation in the healthcare sector.
.jpg "PHOTO_20241123_133653596(1).jpg")
As a leading player in the in vitro diagnostics field, Hipro showcased its latest R&D innovations at the exhibition, drawing significant attention from attendees. The company's booth was consistently bustling with professionals eager to engage in discussions about the latest advancements in diagnostic technology. The event served as a dynamic platform for exchanging ideas and insights with experts, highlighting Hipro's ongoing commitment to pushing the boundaries of in vitro diagnostics.
Hipro showcased an impressive range of products, including the A1, A1plus, microfluidic systems, PalmF, ZOAN home test, and Egoo devices. These offerings highlighted the company’s deep technical expertise and innovative capabilities in the field of in vitro diagnostics, demonstrating its commitment to advancing diagnostic technology and addressing diverse medical needs.
.jpg "PHOTO_20241123_142138828(1).jpg")
ZOAN home test
These product is a serial tests of digestive tract and enable customers to monitor their gastrointestinal health at home in a comprehensive and timely manner.The introduction of this series not only addresses the growing demand for personalized health management but also enhances the convenience and accuracy of family health care. By offering at-home solutions, Hipro empowers individuals to take proactive steps in managing their digestive health with ease and precision.
Specific Protein Detection Series
At Medica2024, Hipro presented its liquid platform products, including the A1 and A1 Plus. Known for their excellence in specific protein testing, these products are tailored to meet the varying demands of medical institutions and laboratories. Each model offers unique features designed for different operational needs. The flagship A1, in particular, drew considerable attention from professionals and buyers at the event. Since its launch, A1 has been well-received across Europe, the Middle East, Southeast Asia, South Asia and other international markets.
(1).png "WPS拼图1(1)(1).png")
Immunofluorescence
The PalmF is a portable testing device introduced by Hipro to meet the needs of primary care organizations and personal health management. It is a compact, portable device supporting tests for diabetes, cardiac conditions, vitamins, and female reproductive hormones, facilitating accessible health diagnostics for all.Since its entry into the European market, PalmF has fostered deep collaborations in countries like Germany, Italy, Switzerland, and the Netherlands. In several regions, these partnerships have expanded to include OEM agreements. These efforts are paving the way for Hipro to strengthen its foothold and establish a lasting presence in the European market.
.jpg "PHOTO_20241123_133443413(1).jpg")
Microfluidics System
Microfluidic technology is another major innovation in in vitro diagnostics from Hipro. By precisely controlling the flow of small liquid volumes within microchannels, this technology enables fast and efficient detection of biological samples. The launch of microfluidic products not only improves test sensitivity and specificity but also significantly reduces testing time. This advancement plays a vital role in emergency and critical care settings, where quick and accurate results are essential for patient care.
.jpg "PHOTO_20241123_133035455(1).jpg")
Hipro’s participation in MEDICA once again highlighted its innovation and dedication to the IVD field. We continuously assess the practical needs of our customers, responding to global expectations with precision. Through our strong research and development capabilities, we create products that are tailored to deliver satisfaction and meet diverse requirements effectively.
We deeply appreciate all the customers and professionals who visited our booth this year. Thank you for your support, and we look forward to welcoming you again at MEDICA 2025 in Düsseldorf!
